Recombinant Human Enolase 2 His-tag Protein, CF Summary
Details of Functionality |
Measured by its ability to convert phosphoglyceric acid to phosphoenolpyruvate. The specific activity is >6,000 pmol/min/μg, as measured under the described conditions. |
Source |
E. coli-derived human Enolase 2/Neuron-specific Enolase protein Met1-Leu434 with an N-terminal Met and 6-His tag
|
Accession # |
|
N-terminal Sequence |
Met |
Protein/Peptide Type |
Recombinant Enzymes |
Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. |
Endotoxin Note |
<0.10 EU per 1 μg of the protein by the LAL method. |
Applications/Dilutions
Dilutions |
|
Theoretical MW |
48 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
SDS-PAGE |
46 kDa, under reducing conditions
|
Packaging, Storage & Formulations
Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 6 months from date of receipt, -20 to -70 °C as supplied.
- 3 months, -20 to -70 °C under sterile conditions after opening.
|
Buffer |
Supplied as a 0.2 μm filtered solution in MES, NaCl, KCl and MgSO4. |
Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. |
Assay Procedure |
- Assay Buffer: 50 mM Tris, 30 mM MgCl2, 200 mM KCl, pH 7.5
- Recombinant Human Enolase 2/Neuron‑specific Enolase His-tag (rhENO-2) (Catalog # 10412-EN).
- Substrate: L-2-Phosphoglyceric acid (2-PG) (Sigma, Catalog # 19710), 100 mM stock in deionized water
- Recombinant Human PKM-2 (PKM-2)
(Catalog #
7244-PK)
- Recombinant Human LDH-A (LDH-A)
(Catalog #
9158-HA)
- Adenosine diphosphate (ADP) (Sigma, Catalog # A2754), 200 mM stock in deionized water
- beta -Nicotinamide adenine dinucleotide, reduced disodium salt hydrate ( beta -NADH) (Sigma, Catalog # N8129), 20 mM stock in 0.1 M Sodium Borate, pH 9.0
- 96-well clear Plate
(Catalog #
DY990)
- Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
- Prepare Reaction Mixture containing 20 µg/mL rhPKM-2, 5 µg/mL rhLDH-A, 14 mM ADP, 800 µM beta -NADH, and 8 mM 2-PG in Assay Buffer.
- Incubate Reaction Mixture at room temperature for 5 minutes.
- Dilute rhENO-2 to 1 µg/mL in Assay Buffer.
- In a plate, load 50 µL of 1 µg/mL rhENO-2, and start the reaction by adding 50 µL of Reaction Mixture. Include a Substrate Blank containing 50 µL of Assay Buffer and 50 µL of Reaction Mixture.
- Read at an absorbance of 340 nm in kinetic mode for 10 minutes with a lag time of 3 minutes.
- Calculate specific activity:
Specific Activity (pmol/min/µg) = | Adjusted Vmax* (OD/min) x well volume (L) x 1012 pmol/mol x (-1) | ext. coeff** (M-1cm-1) x path corr.*** (cm) x amount of enzyme (µg) |
*Adjusted for Substrate Blank **Using the extinction coefficient 6220 M-1cm-1 ***Using the path correction 0.32 cm Note: the output of many spectrophotometers is in mOD Per Well: - rhENO-2: 0.05 µg
- 2-PG: 4 mM
- ADP: 7 mM
- beta -NADH: 400 µM
|
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human Enolase 2 His-tag Protein, CF
Background
Neuron specific enolase (NSE), also known as ENO2 or gamma-enolase, is a dimeric, Mg
2+-dependent enzyme that catalyzes the dehydration of 2-phospho-D glycate (PGA) to phosphoenolpyruvate (PEP) in the glycolytic pathway and catalyzes the reverse reaction in gluconeogenesis. There are three major isozymes of enolase expressed in selective vertebrate tissues from separate genes: alpha (ENO1), beta (ENO3), and gamma (ENO2). NSE is a highly expressed, specific neuron isozyme (1) making it a useful marker for tumors derived from neuronal cells. Neuron-specific enolase is implicated as a diagnostic and prognostic marker in numerous diseases including early small cell lung cancer (2), prostate cancer (3), multiple myeloma (4), traumatic brain injury (5), acute spinal cord injury (6), acute ischemic stroke (7), and post-concussion symptoms (8). NSE expression and activity are increased in neuronal and glial activation and injury (9), risk factors implicated in neurodegenerative disease. Elevation of NSE promotes glycolysis, proliferation, activation and migration through its C-terminus to activate PI3K and MAPK signal transduction pathways (6, 10) while inhibition of enolase has been shown to attenuate inflammatory events (11, 12). NSE can be regulated through cleavage of the C-termini by cathepsin X (13, 14) or inhibited directly by antibiotic SF2312 (15). Inhibition has been proposed as a therapeutic strategy in cancer (16).
- Marangos, P.J. and D.E. Schmechel, (1987) Annu. Rev. Neurosci. 10:269.
- Huang, L. et al. (2017) Oncotarget 38:64358.
- Muoio, B. et al. (2018) Int. J. Markers 33:10.
- Yang, H. et al. (2014) PLoS One. 9:e94304.
- Cheng, F. et al. (2014) PLoS One 9:e106680.
- Haque, A. et al. (2016) Metab. Brain Dis. 31:487.
- Anand, N. et al. (2005) Cerebrovasc. Dis. 20:213.
- Mercier, E. et al. (2018) Brain Inj. 32:29.
- Isgro, M.A. et al. (2015) Adv. Exp. Med. Biol. 867:125.
- Hafner, A. et al. (2013) Aging Cell 12:604.
- Polcyn, R. et al. (2017) J. Clin. Cell. Immunol. 8:536.
- Haque, A. et al. (2017) Neurochem. Res. 42:2777.
- Obermajer, N. et al. (2009) Int. J. Biochem. Cell Biol. 41:1685.
- Hafner, A. et al. (2012) Biochem. J. 443:439.
- Leonard, P.G. et al. (2016) Nat. Chem. Bio. 12:1053.
- Muller, F.L. et al. (2012) Nature. 488:337.
Customers Who Viewed This Item Also Viewed...
Species: Fe, Hu
Applications: ELISA, Flow, Func, ICC/IF, IHC, IHC-P, IP, WB
Species: Bv, Ch, Eq, Gp, Hu, Mu, Po, Rb, Rt
Applications: ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
Species: Ch, Fe, Hu, Pm, Mu, Rt
Applications: ELISA, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
Species: Bv, Ca, Ch, Eq, Hu, Mu, Po, Rt
Applications: ICC/IF, IHC, IHC-Fr, IHC-P, WB
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
Species: Hu, Pm
Applications: CyTOF-ready, Flow, ICC/IF, IHC, IHC-P
Species: Hu
Applications: IHC, WB
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, WB
Species: Hu, Mu
Applications: IHC
Species: Hu
Applications: BA
Species: Hu
Applications: ICC/IF, IHC, IHC-P, KD, WB
Species: Hu, Rt
Applications: ICC/IF, IHC, S-ELISA, WB
Species: Hu, Mu
Applications: IHC, IHC-P, WB
Species: Hu, Mu
Applications: ELISA, Flow, ICC/IF, IHC, IHC-Fr, IHC-P
Species: Hu
Applications: CyTOF-ready, ELISA, Flow, ICC/IF, IHC, IHC-P
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
Species: Hu
Applications: IHC, IHC-P, WB
Species: Bv
Applications: ELISA, ICC/IF, IHC, IHC-Fr, IHC-P, RIA, RI, WB
Species: Hu
Applications: Enzyme Activity
Publications for Enolase 2/Neuron-specific Enolase (10412-EN) (0)
There are no publications for Enolase 2/Neuron-specific Enolase (10412-EN).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for Enolase 2/Neuron-specific Enolase (10412-EN) (0)
There are no reviews for Enolase 2/Neuron-specific Enolase (10412-EN).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
FAQs for Enolase 2/Neuron-specific Enolase (10412-EN) (0)
Additional Enolase 2/Neuron-specific Enolase Products
Blogs on Enolase 2/Neuron-specific Enolase